Novartis AG (NYSE:NVS) reported Q2 17 earnings this Morning, coming in at $1.22 per share, beating Wall Street’s estimates of $1.16 per Share. Revenue for the quarter came in at $12.24 billion beating analyst estimates of $12.20 billion

Analyst Coverage For Novartis AG (NYSE:NVS)
These are 3 Sell Ratings, 7 Hold Ratings, 5 Buy Ratings .
The current consensus rating for Novartis AG (NYSE:NVS) is Hold (Score: 2.13) with a consensus target price of $82.27 , a potential (1.20% downside)

Recent Insider Trading for Novartis AG (NYSE:NVS)

• On 7/5/2017 Bioventures Ltd Novartis, Major Shareholder, bought 266,667 with an average share price of $15.00 per share and the total transaction amounting to $4,000,005.00.
• On 5/11/2016 Institutes For Biomed Novartis, Major Shareholder, bought 277,777 with an average share price of $18.00 per share and the total transaction amounting to $4,999,986.00.
• On 2/17/2016 Bioventures Ltd Novartis, Major Shareholder, bought 375,000 with an average share price of $8.00 per share and the total transaction amounting to $3,000,000.00.
• On 9/22/2014 Bioventures Ltd Novartis, Major Shareholder, bought 325,000 with an average share price of $15.00 per share and the total transaction amounting to $4,875,000.00.

Dividend History for Novartis AG (NYSE:NVS)

• On 1/27/2017 announced a Annual dividend of $2.33 with an ex dividend date of 3/1/2017 which will be payable on 3/3/2017.
• On 2/1/2016 announced a Annual dividend of $2.34 with an ex dividend date of 2/24/2016 which will be payable on 2/26/2016.
• On 2/4/2014 announced a annual dividend of $2.72 3.48% with an ex dividend date of 2/27/2014 which will be payable on 3/3/2014.
• On 2/11/2013 announced a annual dividend of $2.53 3.71% with an ex dividend date of 2/26/2013 which will be payable on 2/28/2013.

Recent Trading for Novartis AG (NYSE:NVS)
Shares of Novartis AG closed the previous trading session at 84.55 up +1.28 1.54% with 1,628,485 shares trading hands.